Balchem Corporation BCPC
173.30 USD -0.24 (-0.14%)
At closeNov 11, 2026, 5:25 PM EST
173.30 0.00 0.00%
After hours · Nov 11, 5:25 PM ET
170.78 Day range 174.12
147.18 52-week range 186.15
- YTD
- +13.00%
- 1 year
- +11.01%
News
seekingalpha.com Balchem: Solid Q3 Performance Support Buy Rating Balchem Corp. delivered a strong Q3, with a record net income of $46.7M and 8.6% revenue growth. Adjusted EBITDA rose 12.5% to $80.3M, with a record 27.6% margin, highlighting operational strength.…
globenewswire.com Balchem Corporation to Participate in Baird's Global Industrial Conference on November 11, 2026 MONTVALE, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in…
marketbeat.com 3 Companies With Room to Pass on Costs to Manage Inflation Despite the Federal Reserve's decision to raise interest rates in September 2026, inflation crept up again that month, with the Consumer Price Index rising 0.6% compared to 0.4% in August. Not all…
benzinga.com HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $210 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and lowers the price target from $215 to $210.
seekingalpha.com Balchem: Record Sales, Great Fundamentals, Priced Fully, Hold Balchem posted strong sales growth of 8.6% during the quarter and free cash flow of $57.9 million. BCPC's business is great—growing earnings, low borrowings, and continuous share buybacks. My DCF…
fool.com Balchem: 3 Key Takeaways for Long-Term Investors Third-quarter net sales rose 8.6% year over year to $291 million. Human nutrition and health segment sales increased 8.1% to $188 million.
seekingalpha.com Balchem Corporation (BCPC) Q3 2026 Earnings Call Transcript Balchem Corporation (BCPC) Q3 2026 Earnings Call Transcript
benzinga.com Balchem Q3 2026 Earnings Call Transcript Balchem (NASDAQ:BCPC) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Balchem Q3 Adj. EPS $1.57 Beats $1.53 Estimate, Sales $290.658M Beat $289.250M Estimate Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.57 per share which beat the analyst consensus estimate of $1.53 by 1.95 percent. This is a 16.3 percent increase over earnings of $1.35 per…
globenewswire.com Balchem Corporation Reports Third Quarter 2026 Financial Results MONTVALE, N.J., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported financial results for its 2026 fiscal third quarter ended September 30, 2026.
benzinga.com American Express, Eni On Deck Friday As Spending, Energy Demand Face Test American Express headlines Friday’s reports, with premium-card spending and consumer resilience the central questions after a sharp year-to-date stock decline. Eni SpA, SLB, Infosys, First Citizens…
globenewswire.com Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026 MONTVALE, N.J., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 23, 2026, at 11:00 AM Eastern Time (ET) to…
globenewswire.com Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026 MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in…
benzinga.com Snowflake To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday Top Wall Street analysts changed their outlook on top names. Barclays raised DAR's target to $65, BTIG boosted SNOW's target to $340, and JP Morgan upgraded LYB to Overweight.
benzinga.com HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $215 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and raises the price target from $190 to $215.
seekingalpha.com Balchem: It's A Buy From Me After Posting Strong Q2 Results Balchem Corporation posted Q2 results, with EPS of $1.49 beating estimates by $0.07, while surpassing the consensus by $15M and was up 11% YoY. All areas of the business posted impressive results, as…
seekingalpha.com Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript
seekingalpha.com Conestoga SMid Cap Composite Q2 2026 Portfolio Review West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler…
benzinga.com Balchem Q2 Adj. EPS $1.49 Beats $1.40 Estimate, Sales $283.997M Beat $268.502M Estimate Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.40 by 6.43 percent. This is a 17.32 percent increase over earnings of $1.27 per…
globenewswire.com Balchem Corporation Reports Second Quarter 2026 Financial Results MONTVALE, N.J., July 31, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported financial results for its 2026 fiscal second quarter ended June 30, 2026.
globenewswire.com Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026 MONTVALE, N.J., July 17, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 31, 2026, at 11:00 AM Eastern Time (ET) to…
globenewswire.com Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026 MONTVALE, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in…
globenewswire.com Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026 MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in…- benzinga.com HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $5.16 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and raises the price target from $5.1 to $5.16.
benzinga.com Balchem Q1 2026 Earnings Call Transcript 
seekingalpha.com Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
benzinga.com Earnings Scheduled For April 30, 2026 - benzinga.com Balchem Q1 Adj. EPS $1.33, Inline, Sales $270.709M Beat $266.504M Estimate Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.33 per share which met the analyst consensus estimate. This is a 9.02 percent increase over earnings of $1.22 per share from the same period…
globenewswire.com Balchem Corporation Reports First Quarter 2026 Financial Results MONTVALE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2026 fiscal first quarter ended March 31, 2026.
zacks.com Sherwin-Williams (SHW) Beats Q1 Earnings and Revenue Estimates Sherwin-Williams (SHW) came out with quarterly earnings of $2.35 per share, beating the Zacks Consensus Estimate of $2.24 per share. This compares to earnings of $2.25 per share a year ago.
seekingalpha.com Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings The Conestoga SMid Cap Composite returned -10.24% net-of-fees in the first quarter, lagging the Russell 2500 Growth Index's return of -3.52%. RBC's performance was driven by continued strength in…
benzinga.com Balchem Launches Free Digital Tool to Help Farmers Improve Crop Nutrition Balchem Plant Nutrition, a global leader in chelated mineral plant nutrition and the maker of Metalosate® micronutrients, today announced the launch of its Metalosate® T.E.A.M.™ plant tissue analysis- benzinga.com HC Wainwright & Co. Maintains Buy on Balchem, Maintains $190 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and maintains $190 price target.
benzinga.com Balchem Earnings Report: Q4 Overview - benzinga.com Balchem Q4 Adj. EPS $1.31 Beats $1.28 Estimate, Sales $263.617M Beat $259.585M Estimate Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1.28 by 1.95 percent. This is a 15.93 percent increase over earnings of $1.13 per…
- benzinga.com Earnings Scheduled For February 20, 2026
benzinga.com Earnings Outlook For Balchem 
benzinga.com Rothschild & Co Initiates Coverage On Balchem with Neutral Rating, Announces Price Target of $162 Rothschild & Co analyst Artem Chubarov initiates coverage on Balchem (NASDAQ:BCPC) with a Neutral rating and announces Price Target of $162.
benzinga.com HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $190 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and raises the price target from $189 to $190.- benzinga.com Balchem Q3 Adj. EPS $1.35 Beats $1.31 Estimate, Sales $267.558M Beat $258.282M Estimate Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.31 by 3.05 percent. This is a 19.47 percent increase over earnings of $1.13 per…
benzinga.com Earnings Scheduled For October 21, 2025 - benzinga.com Balchem's Earnings Outlook
- benzinga.com HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $189 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and raises the price target from $180 to $189.
benzinga.com Balchem Q2 Adj. EPS $1.27 Beats $1.25 Estimate, Sales $255.467M Beat $250.313M Estimate Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.25 by 1.6 percent. This is a 16.51 percent increase over earnings of $1.09 per…- benzinga.com Earnings Scheduled For July 31, 2025
- benzinga.com HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $180 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and lowers the price target from $190 to $180.
- benzinga.com Balchem Q1 Adj. EPS $1.22, Inline, Sales $250.52M Beat $245.70M Estimate Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.22 per share which met the analyst consensus estimate. This is a 18.45 percent increase over earnings of $1.03 per share from the same period…
- benzinga.com Earnings Scheduled For April 24, 2025
- benzinga.com What's Next: Balchem's Earnings Preview
- benzinga.com HC Wainwright & Co. Reiterates Buy on Balchem, Maintains $190 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Balchem (NASDAQ:BCPC) with a Buy and maintains $190 price target.